Our qualitative research with patients who have experienced significant weight loss reveals critical gaps in care that represent both challenges and opportunities for healthcare stakeholders.
A growing majority of Americans (74% up from 66% a year ago) see new medications showing potential to treat obesity, according to new data from the Ipsos Consumer Tracker.
Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.
More than half of Americans would be interested in taking a new 'safe and effective' weight loss treatment, according to new data from the Ipsos Consumer Tracker